Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis
Titel:
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis
Auteur:
Reginster, Jean-Yves Czerwinski, Edward Wilk, Krzysztof Borowy, Przemysław Strzelecka, Anna Budlewski, Tomasz Janowska-Maus, Monika Szymanowski, Krzysztof Kwiatek, Joanna Postol, Svitlana Põder, Airi Supronik, Jerzy Kim, SungHyun Suh, JeeHye Han, NooRi Kim, NaHyun Bae, SeoHee Silverman, Stuart L.